Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2021-04-07 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Disclosure under SEBI Takeover Regulations
Regulatory Filings
2021-04-07 English
Intimation of Issue of Duplicate Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the issuance of duplicate share certificates. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate management. The content is about share certificate replacement and does not contain financial data, management discussion, voting results, or any report publication. It is a regulatory announcement related to share certificates but does not fit into categories like Share Issue/Capital Change or Transaction in Own Shares since it is about duplicate certificates. The best fitting category is Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-04-05 English
Loss of Share Certificates
Major Shareholding Notification Classification · 60% confidence The document contains a table listing shareholders with folio numbers, share counts, and certificate numbers. It appears to be a record of share certificates or shareholding details. There is no indication of financial data, report publication, voting results, or management information. The document is very short (459 characters) and does not fit into categories like Annual Report, Earnings Release, or Regulatory Filings. It is not a report or announcement but a factual shareholder record. Given the options, none perfectly match, but the closest fit is Major Shareholding Notification (MRQ) since it relates to shareholding details, although it does not explicitly mention threshold changes. However, since it is a shareholder list, MRQ is the best classification. Confidence is moderate due to limited context.
2021-04-05 English
Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements Regulations, 2015. It announces the acquisition of 100% ownership interest in Pharmarack Technologies Private Limited by a wholly owned entity of the listed company. The document includes details required under SEBI circular CIR/CFD/CMD/4/2015 dated September 9, 2015, which pertains to disclosures of material events or information. The content is an announcement of a capital acquisition transaction, not a full financial report or detailed analysis. It is not a full Annual Report, Interim Report, or Earnings Release. It is not a proxy, voting result, or management report. The document is a regulatory announcement about a capital transaction (acquisition). Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length is substantial and contains detailed disclosure, supporting this classification with high confidence.
2021-04-01 English
Updates
M&A Activity Classification · 95% confidence The document text primarily discusses the acquisition of Pharmarack Technologies Private Limited by DigiHealth Technologies LLP, detailing the target entity, acquisition percentage, cost, nature of consideration, and background information about the acquired entity. The content focuses on the specifics of the acquisition transaction, including shareholding percentages, payment method, and strategic rationale. There is no indication of this being a full annual or interim financial report, audit report, or earnings release. The document is not a regulatory filing or announcement of a report publication but rather a detailed announcement of a merger/acquisition activity. Therefore, the document fits best under the category of M&A Activity (Code: TAR). The document length is under 5,000 characters, but the content is substantive about the acquisition details, not merely an announcement of a report publication.
2021-04-01 English
Updates
Capital/Financing Update Classification · 95% confidence The document is an intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, regarding the acquisition of a controlling stake in a company (AIOCD Pharmasofttech Awacs Private Limited) by the investee entity of the listed company. It provides detailed information about the acquisition, including the percentage of shares acquired, cost, background of the acquired entity, and regulatory compliance details. This type of filing is a disclosure of a material event or corporate action related to capital structure or investment activities. It is not a full financial report, earnings release, or management discussion, nor is it a voting result or board change announcement. The document is a regulatory announcement about a capital transaction, fitting the category of Capital/Financing Update (CAP). The document length is 6741 characters, which is sufficient for a detailed announcement rather than a brief notice. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2021-03-31 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.